Skip to main content
SpringerLink
Log in

Hematuria in the Critically Ill Cancer Patients

  • Living reference work entry
  • First Online:
Oncologic Critical Care

  • 246 Accesses

Abstract

Hematuria is a common problem caused by numerous diseases such as infection, urolithiasis, and increasingly malignancy. The finding can be burdensome to the patient and clinician alike due to the associated morbidities and challenges in diagnosing potentially life-threatening etiologies. A lack of a consensus on guidelines for evaluation persists which has complicated the physician’s decision-making process. This chapter reviews the current literature and seeks to highlight the current trends in diagnosis and outcomes particularly in critically ill cancer patients and special patient populations. Conclusively, prospective studies are needed to evaluate to streamline and update current guidelines for hematuria. Also, a structured and reflexive protocol across the system level will address the disparities and outcomes in certain demographic populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Abdullah Sumnu MG, Ozturk S. Primary glomerular diseases in the elderly. World J Nephrol. 2015;4(2): 263–70.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Alves M, Moreno R, Rodrigues F, et al. Hematuria as the first sign of multiple myeloma. Clin Case Rep. 2017;5(8):1358–61.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ansari M, Vukicevic M, Rougemont AL, et al. Do NK cells contribute to the Pathophysiology of transplant-associated Thrombotic Microangiopathy? Am J Transplant. 2011;11(8):1748–52.

    Article  CAS  PubMed  Google Scholar 

  4. Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology. 2000;55(1):22–4.

    Article  CAS  PubMed  Google Scholar 

  5. Bassett JC, Alvarez J, Koyama T, et al. Gender, race, and variation in the evaluation of microscopic hematuria among medicare beneficiaries. J Gen Intern Med. 2015;30(4):440–7.

    Article  PubMed  Google Scholar 

  6. Bell GM, Williams P, Thomson D. Is the loin pain and haematuria syndrome a renal manifestation of hypersensitivity? Lancet (London). 1984;1(8372):340.

    Article  CAS  Google Scholar 

  7. Bhuvanagiri AK, Kannan S, Gundupalli D, et al. Association between haematuria and urinary tract calculi. Eur Urol Suppl. 2018;17(5):e2230.

    Article  Google Scholar 

  8. Buteau A, Seideman CA, Svatek RS, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol Semin Original Investig. 2014;32(2):128–34.

    Article  Google Scholar 

  9. Carvalho M, Velho PHI, Silva GBG, et al. A shocking hematuria. QJM Int J Med. 2015;108(1):55–7.

    Article  CAS  Google Scholar 

  10. Claudia Yuste EG, Sevillano AM, et al. Pathogenesis of glomerular haematuria. World J Nephrol. 2015;4(2):185–95.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cohen RA, Brown RS. Microscopic Hematuria. N Engl J Med. 2003;348(23):2330–8.

    Article  PubMed  Google Scholar 

  12. Cohn JA, Vekhter B, Lyttle C, et al. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer. 2014;120(4):555–61.

    Article  PubMed  Google Scholar 

  13. Critchlow WA, Stern KL, Jameson JJ, et al. Retained nephrostomy string causing severe flank pain and hematuria. J Vasc Interv Radiol. 2017;28(9):1308–10.

    Article  PubMed  Google Scholar 

  14. Cui ZMD, Zhao JMD, Jia X-YP, et al. Clinical features and outcomes of anti–glomerular basement membrane disease in older patients. Am J Kidney Dis. 2011;57(4):575–82.

    Article  PubMed  Google Scholar 

  15. Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of Asymptomatic Microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6, Supplement):2473–81.

    Article  PubMed  Google Scholar 

  16. Elias K, Svatek RS, Gupta S, et al. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 2010;116(12):2954–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Flagg L, Parish AL. Hematuria to bladder cancer management timeliness: a baseline study at a veterans affairs facility. J Nurs Pract. 2016;12(4):235–42.

    Article  Google Scholar 

  18. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by Interferon Alfa-2b compared with Interferon Alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655–9.

    Article  CAS  PubMed  Google Scholar 

  19. Fogazzi GB, Fogazzi GB, Ponticelli C, et al. Microscopic hematuria diagnosis and management. Nephron. 1996;72(2):125–34.

    Article  CAS  PubMed  Google Scholar 

  20. Friedlander DF, Resnick MJ, You C, et al. Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Am J Med. 2014;127(7):633–640.e611.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Garg T, Pinheiro LC, Atoria CL, et al. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014;192(4):1072–7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gomez CR, Nomellini V, Faunce DE, et al. Innate immunity and aging. Exp Gerontol. 2008;43(8): 718–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy – Part I: definition, detection, prevalence, and etiology11The Asymptomatic Microscopic Hematuria in Adults Best Practice Policy has been published in summary format in American Family Physician, Volume 63, March 15, 2001. Urology. 2001;57(4): 599–603.

    Article  CAS  PubMed  Google Scholar 

  24. Halpern JA, Chughtai B, Ghomrawi H. Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria. JAMA Intern Med. 2017;177(6):800–7.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Han SS, Ahn SY, Ryu J, et al. Proteinuria and hematuria are associated with acute kidney injury and mortality in critically ill patients: a retrospective observational study. BMC Nephrol. 2014;15(1):93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Hassan EA, Ali TZ, Abdulbaki A, et al. Histopathologic findings of potential kidney donors with asymptomatic microscopic hematuria: impact on donation. Transplant Proc. 2017;49(8):1729–32.

    Article  CAS  PubMed  Google Scholar 

  27. Hu R, Xing G, Wu H, et al. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases. Diagn Pathol. 2016;11(1):86.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Imai N, Shirai S, Shibagaki Y, et al. Nutcracker phenomenon in IgA nephropathy. Clin Kidney J. 2014;7(3):325–6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Javanmard B, Yousefi MR, Fadavi B, et al. Retained surgical gauze presenting with gross hematuria: a case report. Urol J. 2017;14(5):5027–9.

    PubMed  Google Scholar 

  30. Javanmard B, Haghighat Khah H, Fallah-Karkan M, et al. Recurrent hematuria in renal angio-venous malformation, delay diagnosis and endovascular treatment, a case report. Urol Case Rep. 2018;16:46–7.

    Article  PubMed  Google Scholar 

  31. Jimbo M. Evaluation and management of hematuria. Prim Care. 2010;37(3):461–72.

    Article  PubMed  Google Scholar 

  32. Johnson EK, Daignault S, Zhang Y, et al. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology. 2008;72(3):498–502.

    Article  PubMed  Google Scholar 

  33. Khan MA, Shaw G, Paris AMI. Is microscopic haematuria a urological emergency? BJU Int. 2002;90(4):355–7.

    Article  CAS  PubMed  Google Scholar 

  34. Kim S, Choi K, Huh K, et al. The significance of post-transplant microscopic hematuria in renal transplant patient. Transplantation. 2004;78(2):249–50.

    Article  Google Scholar 

  35. Knoll T. Epidemiology, pathogenesis, and pathophysiology of Urolithiasis. Eur Urol Suppl. 2010;9(12): 802–6.

    Article  CAS  Google Scholar 

  36. Kobayashi Y, Hiki Y, Kokubo T, et al. Steroid therapy during the early stage of progressive IgA nephropathy – a 10-year follow-up study. Nephron. 1996;72(2):237–42.

    Article  CAS  PubMed  Google Scholar 

  37. Koratala A, Chamarthi G, Segal MS. Not all that is red is blood: a curious case of chromaturia. Clin Case Rep. 2018;6(6):1179–80.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Leaker BS, Leaker BR, Gordge MP, et al. Haemostatic changes in the loin pain and haematuria syndrome: secondary to renal vasospasm? QJM. 1990;76(281): 969–79.

    CAS  PubMed  Google Scholar 

  39. Lech M, Anders H-J. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lin J, Cheng Z, Qian Q. Elderly patients with glomerular diseases and IgA nephropathy. Nephrology. 2017;22(S4):20–6.

    Article  PubMed  Google Scholar 

  41. Locatelli F, Del Vecchio L, Pozzi C. The patient with IgA glomerulonephritis – what is the role of steroid treatment? Nephrol Dial Transplant. 1999;14(5): 1057–60.

    Article  CAS  PubMed  Google Scholar 

  42. Low AI, Matz LR. Hæmaturia and renal fornical lesions. Br J Urol. 1972;44(6):681–91.

    Article  CAS  PubMed  Google Scholar 

  43. Luo J-D, Liu B, Wang P, et al. External iliac vein – transplant ureteral fistula combined with renal cell carcinoma: an unusual case of hematuria. OncoTargets Ther. 2014;7:1339–42.

    Google Scholar 

  44. Ma Z, Liu X, Ning Y, et al. Nutcracker phenomenon in combination with glomerular nephritis in isolated hematuria patients. Int Urol Nephrol. 2013;45(3): 809–16.

    Article  CAS  PubMed  Google Scholar 

  45. Mariani AJ, Mariani MC, Macchioni C, et al. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350–5.

    Article  CAS  PubMed  Google Scholar 

  46. Mcdonald MM, Swagerty D, Wetzel L. Assessment of microscopic hematuria in adults. Am Fam Physician. 2006;73(10):1748–54.

    PubMed  Google Scholar 

  47. Miller F, Lane BP, Kirsch M, et al. Loin pain-hematuria syndrome with a distinctive vascular lesion and alternative pathway complement activation. Arch Pathol Lab Med. 1994;118(10):1016–9.

    CAS  PubMed  Google Scholar 

  48. Mishriki S. MP06-07 long-term outcome of hematuria – prospective large cohort. J Urol. 2018;199(4):e54.

    Google Scholar 

  49. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2007;356(2):115–24.

    Article  CAS  PubMed  Google Scholar 

  50. Muraoka N, Sakai T, Kimura H, et al. Rare causes of hematuria associated with various vascular diseases involving the upper urinary tract. Radiographics. 2008;28(3):855–67.

    Article  PubMed  Google Scholar 

  51. Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22(1):187–95.

    Article  PubMed  Google Scholar 

  52. Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol Semin Original Invest. 2010;28(5):500–3.

    Article  Google Scholar 

  53. Nielsen M, Qaseem A, Amer Coll P, et al. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American college of physicians. Ann Intern Med. 2016;164(7):488–97.

    Article  PubMed  Google Scholar 

  54. Niemi MA, Cohen RA. Evaluation of microscopic hematuria: a critical review and proposed algorithm. Adv Chronic Kidney Dis. 2015;22(4):289–96.

    Article  PubMed  Google Scholar 

  55. O’connor OJ, Mcsweeney SE, Maher MM. Imaging of hematuria. Radiol Clin N Am. 2008;46(1):113–32.

    Article  PubMed  Google Scholar 

  56. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166(5):1611–23.

    Article  CAS  PubMed  Google Scholar 

  57. Paratore DA, Herts BR. Castleman disease. J Urol. 2015;194(2):529–30.

    Article  PubMed  Google Scholar 

  58. Patel JV, Chambers CV, Gomella LG. Hematuria: etiology and evaluation for the primary care physician. Can J Urol. 2008;15:54–62.

    PubMed  Google Scholar 

  59. Praga M, Martínez MA, Andrés A, et al. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int. 1998;54(3):915–20.

    Article  CAS  PubMed  Google Scholar 

  60. Purpurowicz Z, Roslan M, Purpurowicz Ł, et al. Hematuria from urinary ascariasis. Kidney Int. 2017;91(6):1521.

    Article  PubMed  Google Scholar 

  61. Raghavan R, Date A, Bhaktaviziam A. Fungal and nocardial infections of the kidney. Histopathology. 1987;11(1):9–20.

    Article  CAS  PubMed  Google Scholar 

  62. Raman JD, Sosa RE, Vaughan ED, et al. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology. 2007;69(2):251–4.

    Article  PubMed  Google Scholar 

  63. Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–6.

    Article  PubMed  Google Scholar 

  64. Richards KA, Ham S, Cohn JA, et al. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the medicare population: implications for sex disparities. Int J Urol. 2016;23(1):42–7.

    Article  PubMed  Google Scholar 

  65. Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz RR, et al. Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis. 2010;10(1):245.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Rockall AG, Newman-Sanders AP, Al-Kutoubi MA, et al. Haematuria. Postgrad Med J. 1997;73(857): 129–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Rodríguez Cabello MA, Sanz Miguelañez JL, Garrido Abad P, et al. Primary arteriocalicial fistula: a dangerously rare cause of hematuria. Urol Case Rep. 2018;19:18–9.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Samson P, Waingankar N, Shah P, et al. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria. Urol Oncol Semin Original Invest. 2018;36(1):10.e11–6.

    Google Scholar 

  69. Saundby R. The diagnostic significance of hematuria. Br Med J. 1887;2(1407):1320–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Schmitz-Dräger BJ, Kuckuck EC, Zuiverloon TCM, et al. Microhematuria assessment an IBCN consensus – based upon a critical review of current guidelines. Urol Oncol Semin Original Invest. 2016;34(10): 437–51.

    Article  Google Scholar 

  71. Shinagare A, Silverman S, Gershanik E, et al. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis. Am J Med. 2014;127(7): 625–32.

    Article  PubMed  Google Scholar 

  72. Siegler RL, Siegler RL, Brewer ED, et al. Platelet activation and prostacyclin supporting capacity in the loin pain hematuria syndrome. Am J Kidney Dis. 1988;12(2):156–60.

    Article  CAS  PubMed  Google Scholar 

  73. Smith HS, Bajwa ZH. Loin pain hematuria syndrome – visceral or neuropathic pain syndrome? Clin J Pain. 2012;28(7):646–51.

    Article  PubMed  Google Scholar 

  74. Subak LL, Grady D. Asymptomatic microscopic hematuria – rethinking the diagnostic algorithm. JAMA Intern Med. 2017;177(6):808–9.

    Article  PubMed  Google Scholar 

  75. Suzuki T, Imai N, Hisamichi M, et al. Can nutcracker phenomenon cause glomerular hematuria? Nephrology. 2018;23(5):495.

    Article  PubMed  Google Scholar 

  76. Taba Taba Vakili S, Alam T, Sollinger H. Loin pain hematuria syndrome. Am J Kidney Dis. 2014;64(3): 460–72.

    Article  PubMed  Google Scholar 

  77. Tan WS, Feber A, Sarpong R, et al. Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients. Eur Urol. 2018;74(1):10–4.

    Article  PubMed  Google Scholar 

  78. Tolofari SK, Chow W-M, Hussain B. Castleman’s disease: an interesting cause of hematuria. Urol Case Rep. 2015;3(2):24–6.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Tolofari S, Ansari A, Knight RJ. A rare case of hematuria; primary amyloidosis of the bladder neck. Urol Case Rep. 2017;10:48–50.

    Article  PubMed  Google Scholar 

  80. Varma PP, Sengupta P, Nair RK. Post exertional hematuria. Ren Fail. 2014;36(5):701–3.

    Article  CAS  PubMed  Google Scholar 

  81. Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control. 2000;11(10):933–9.

    Article  CAS  PubMed  Google Scholar 

  82. Wade H. A British medical association lecture on the significance of haematuria. Br Med J. 1932;1(3708): 177–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Wang Z, Vathsala A, Tiong HY. Haematuria in postrenal transplant patients. Biomed Res Int. 2015;2015:8.

    Google Scholar 

  84. Woolfson RG, Lewis CA, Hill PD, et al. Ureteric peristalsis studies in loin pain and haematuria syndrome: another diagnostic disappointment. Br J Urol. 1993;72(3):291–2.

    Article  CAS  PubMed  Google Scholar 

  85. Woolhandler S, Pels RJ, Bor DH, et al. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders: I. hematuria and proteinuria. JAMA. 1989;262(9):1214–9.

    Article  CAS  PubMed  Google Scholar 

  86. Ziemba J, Guzzo TJ, Ramchandani P. Evaluation of the patient with asymptomatic microscopic hematuria. Acad Radiol. 2015;22(8):1034–7.

    Article  PubMed  Google Scholar 

  87. Zubair AS, Salameh H, Erickson SB, et al. Loin pain hematuria syndrome. Clin Kidney J. 2016;9(1): 128–34.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UTHealth and MD Anderson Cancer Center, Houston, TX, USA

    Chukwuma O. Kalu

  2. Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Ala Abudayyeh

Authors
  1. Chukwuma O. Kalu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ala Abudayyeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ala Abudayyeh .

Editor information

Editors and Affiliations

  1. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Joseph L. Nates

  2. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Kristen J. Price

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kalu, C.O., Abudayyeh, A. (2019). Hematuria in the Critically Ill Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_76-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74698-2_76-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74698-2

  • Online ISBN: 978-3-319-74698-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation